Diferencia entre revisiones de «Unfractionated heparin»

(Switch SMW query from broadtable to table format for better layout with TOC)
 
(No se muestran 13 ediciones intermedias de 9 usuarios)
Línea 1: Línea 1:
==General==
==General==
*Type: Anticoagulant
*Type: [[Anticoagulant]]
*Dosage Forms: IV, SC
*Dosage Forms: IV, SC
*Common Trade Names: Heparin
*Common Trade Names: Heparin
Línea 8: Línea 8:
*Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)
*Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)
*Then drip: 18 units/kg/h IV (MAX: 1,000 units/h)
*Then drip: 18 units/kg/h IV (MAX: 1,000 units/h)
*Adjust dose to target aPTT levels based on nomogram
===Acute Coronary Syndrome===
*Bolus: 50 units/kg IV x 1 (MAX: 5,000 units)
*Then drip: 12 units/kg/h IV (MAX: 1,000 units/h)
*Adjust dose to target aPTT levels based on nomogram
*Adjust dose to target aPTT levels based on nomogram


Línea 16: Línea 21:


==Special Populations==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: Safe in pregnancy
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
*Lactation:  
*[[Lactation risk categories|Lactation risk]]: Infant risk minimal
*Renal Dosing
*Renal Dosing
**No adjustment
**No adjustment
Línea 26: Línea 31:
*Allergy to class/drug
*Allergy to class/drug
*33% of patients develop some form of bleeding complication; 2-6% develop major bleeding
*33% of patients develop some form of bleeding complication; 2-6% develop major bleeding
*Heparin-Induced Thrombocytopenia
*[[HIT (Heparin-Induced Thrombocytopenia)]]
*See [[HIT (Heparin-Induced Thrombocytopenia)]]


===Risk Factors for Major Bleeding Complication===
===Risk Factors for Major Bleeding Complication===
Línea 36: Línea 40:
*Liver failure
*Liver failure
*Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs
*Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs
==Adverse Reactions==
===Serious===
*Major bleeding
*Thrombocytopenia
===Common===
*Injection site reaction<ref>Warnock LB, Huang D. Heparin. [Updated 2022 Jul 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538247/</ref>
*Hyperkalemia
*Alopecia
*Osteoporosis


==Pharmacology==
==Pharmacology==
Línea 46: Línea 61:
*Must give IV (not subq) for acute thromboembolic disease
*Must give IV (not subq) for acute thromboembolic disease
**Unpredictable anticoagulation effect
**Unpredictable anticoagulation effect
**Must monitor w/ PTT; therapeutic range is 1.5-2.5x normal value
**Must monitor with PTT; therapeutic range is 1.5-2.5x normal value
 
 
==Indications by Condition==
''The following table is automatically generated from disease/condition pages across WikEM.''
 
{{#ask:[[Has DrugName::Unfractionated heparin]]
|?Has Indication=Indication
|?Has Dose=Dose
|?Has Context=Context
|?Has Route=Route
|?Has Population=Population
|format=table
|headers=plain
|mainlabel=-
|sort=Has Indication
|limit=50
}}


==See Also==
==See Also==
*[[Coagulopathy (Main)]]
*[[Unfractionated heparin reversal]]
*[[Low Molecular Weight Heparin]]
*[[Coagulopathy (main)]]
*[[Heparin reversal]]
*[[Low molecular weight heparin]]


==References==
==References==

Revisión actual - 21:55 20 mar 2026

General

  • Type: Anticoagulant
  • Dosage Forms: IV, SC
  • Common Trade Names: Heparin

Adult Dosing

Thromboembolism

  • Bolus: 80 units/kg IV x 1 (MAX: 5,000 units)
  • Then drip: 18 units/kg/h IV (MAX: 1,000 units/h)
  • Adjust dose to target aPTT levels based on nomogram

Acute Coronary Syndrome

  • Bolus: 50 units/kg IV x 1 (MAX: 5,000 units)
  • Then drip: 12 units/kg/h IV (MAX: 1,000 units/h)
  • Adjust dose to target aPTT levels based on nomogram

Pediatric Dosing

  • IV infusion
    • Initial loading dose 75 units/kg given over 10 minutes
    • Initial maintenance dose 20 units/kg/hour and adjest per local policy

Special Populations

Contraindications

Risk Factors for Major Bleeding Complication

  • Recent surgery or trauma
  • Renal failure
  • Alcoholism
  • Malignancy
  • Liver failure
  • Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs

Adverse Reactions

Serious

  • Major bleeding
  • Thrombocytopenia

Common

  • Injection site reaction[1]
  • Hyperkalemia
  • Alopecia
  • Osteoporosis

Pharmacology

  • Half-life: 1.5 hrs
  • Metabolism: Hepatic
  • Excretion: Urine
  • Mechanism of Action:
    • Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin
  • Anticoagulation effect lasts up to 3hr after stopping infusion
  • Must give IV (not subq) for acute thromboembolic disease
    • Unpredictable anticoagulation effect
    • Must monitor with PTT; therapeutic range is 1.5-2.5x normal value


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Acute arterial ischemia80 units/kg bolus, then 18 units/kg/hr infusionAnticoagulation to prevent clot propagationIVAdult
Non-ST-elevation myocardial infarction60-70 units/kg bolus (max 5000), then 12-15 units/kg/hr (max 1000/hr)Antithrombotic; consider if PCI/CABG within 24hr or renal failureIVAdult
Pulmonary embolism80 units/kg IV bolus, then 18 units/kg/hr continuous infusionAnticoagulation (preferred if rapid reversal needed)IV dripAdult
ST-segment elevation myocardial infarction60 units/kg IV bolus (max 4000 U), then 12 units/kg/hr (max 1000 U/hr); titrate to PTT 1.5-2.5x controlAnticoagulation (required with thrombolytics/PCI)IV dripAdult
Unstable angina60 units/kg IV bolus (max 4000 units), then 12 units/kg/hr (max 1000 units/hr)AntithromboticIVAdult

See Also

References

  1. Warnock LB, Huang D. Heparin. [Updated 2022 Jul 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538247/